These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16491164)

  • 1. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.
    Collister KA; Albensi BC
    Drug News Perspect; 2005 Dec; 18(10):623-9. PubMed ID: 16491164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
    Yates LL; Górecki DC
    Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Abeta production by NF-kappaB inhibitors.
    Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
    Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the CREB pathway for memory enhancers.
    Tully T; Bourtchouladze R; Scott R; Tallman J
    Nat Rev Drug Discov; 2003 Apr; 2(4):267-77. PubMed ID: 12669026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
    Wong ET; Tergaonkar V
    Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
    Egan LJ; Toruner M
    Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production.
    Valerio A; Boroni F; Benarese M; Sarnico I; Ghisi V; Bresciani LG; Ferrario M; Borsani G; Spano P; Pizzi M
    Eur J Neurosci; 2006 Apr; 23(7):1711-20. PubMed ID: 16623827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
    Granic I; Dolga AM; Nijholt IM; van Dijk G; Eisel UL
    J Alzheimers Dis; 2009; 16(4):809-21. PubMed ID: 19387114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic protein complexes regulate NF-kappaB signaling.
    Wegener E; Krappmann D
    Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating the regulator: NF-kappaB signaling in heart.
    Hall G; Hasday JD; Rogers TB
    J Mol Cell Cardiol; 2006 Oct; 41(4):580-91. PubMed ID: 16949095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
    Perkins ND
    Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB functions in the nervous system: from development to disease.
    Mémet S
    Biochem Pharmacol; 2006 Oct; 72(9):1180-95. PubMed ID: 16997282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of nuclear factor kappa B by different agents: influence of culture conditions in a cell-based assay.
    Hellweg CE; Arenz A; Bogner S; Schmitz C; Baumstark-Khan C
    Ann N Y Acad Sci; 2006 Dec; 1091():191-204. PubMed ID: 17341614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.
    Bourne KZ; Ferrari DC; Lange-Dohna C; Rossner S; Wood TG; Perez-Polo JR
    J Neurosci Res; 2007 May; 85(6):1194-204. PubMed ID: 17385716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor cross-talk: the estrogen receptor and NF-kappaB.
    Kalaitzidis D; Gilmore TD
    Trends Endocrinol Metab; 2005 Mar; 16(2):46-52. PubMed ID: 15734144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of NF-kappaB signaling: 785 and counting.
    Gilmore TD; Herscovitch M
    Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms.
    Pizzi M; Spano P
    Eur J Pharmacol; 2006 Sep; 545(1):22-8. PubMed ID: 16854410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.